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Abstract
Background: Reduced muscular strength in the old age is strongly related to activity impairment and mortality.
However, studies evaluating the gender-specific association between muscularity and mortality among older adults
are lacking. Thus, the objective of the present study was to examine gender differences in the association between
muscular strength and mortality in a prospective population-based cohort study.
Methods: Data used in this study derived from the Cooperative Health Research in the Region of Augsburg
(KORA)-Age Study. The present analysis includes 1,066 individuals (mean age 76 ± 11 SD years) followed up over
3 years. Handgrip strength was measured using the Jamar Dynamometer. A Cox proportional hazard model was
used to determine adjusted hazard ratios of mortality with 95% confidence intervals (95% CI) for handgrip strength.
Potential confounders (i.e. age, nutritional status, number of prescribed drugs, diseases and level of physical activity)
were pre-selected according to evidence-based information.
Results: During the follow-up period, 56 men (11%) and 39 women (7%) died. Age-adjusted mortality rates per
1,000 person years (95% CI) were 77 (59–106), 24 (13–41) and 14 (7–30) for men and 57 (39–81), 14 (7–27) and 1
(0–19) for women for the first, second and third sex-specific tertile of muscular strength, respectively. Low handgrip
strength was significantly associated with all-cause mortality among older men and women from the general
population after controlling for significant confounders. Hazard ratios (95% CI) comparing the first and second
tertile to the third tertle were 3.33 (1.53–7.22) and 1.42 (0.61-3.28), respectively. Respective hazard ratios (95% CI) for
mortality were higher in women than in men ((5.23 (0.67–40.91) and 2.17 (0.27–17.68) versus 2.36 (0.97–5.75) and 0.
97 (0.36–2.57)).
Conclusions: Grip strength is inversely associated with mortality risk in older adults, and this association is
independent of age, nutritional status, number of prescribed drugs, number of chronic diseases and level of
physical activity. The association between muscular strength and all-cause mortality tended to be stronger in
women. It seems to be particularly important for the weakest to enhance their levels of muscular strength in order
to reduce the risk of dying early.
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Background
Ageing is typically associated with a progressive loss of
skeletal muscle mass in combination with a concomitant
increase in body fat mass [1]. The decline in skeletal
muscle mass (defined as sarcopenia) occurs at a rate of
3–8% each decade after the age of 30 years and has been
linked to increased morbidity and mortality in older
people [2–4]. Recently, low absolute grip strength was
the predominant predictor of clinical outcomes, whereas
low lean mass was not a consistent predictor of mortal-
ity in the Foundation for the National Institutes of
Health (FNIH) Sarcopenia Project [5].
In the last decade, evidence from epidemiological
studies has shown that muscular strength is inversely
associated with all-cause mortality in middle-aged and
older individuals [6–10], even after adjustment for several
confounders including levels of physical activity and
cardiorespiratory fitness. Furthermore, similar associations
have been reported in several clinical populations, suggest-
ing that muscular strength protects against mortality not
only in healthy but also in diseased individuals [11].
However, little is known about the level of muscular
strength required to protect against the risk of death. In
an observational study, similar risk reductions were
reported in men with medium versus high muscular
strength [9, 12], suggesting that high levels of muscular
strength in comparison to moderate levels do not pro-
vide additional protection regarding all-cause mortality.
In contrast, a meta-analysis by Cooper et al. [12] showed a
linear mortality risk reduction with higher grip strength in
community dwelling men and women of any age. A recent
study observed regional and gender-specific associations
of muscle strength with mortality in older people [13].
Risk of death was significantly lower only in women with
high grip strength, but declined linearly with increasing
grip strength in men [13]. Similarly, other studies found
differences in the relationship between muscular strength
and mortality between older men and women [7, 14].
Therefore, the purpose of our study was to examine the




Data used in this study were derived from the Cooperative
Health Research in the Region of Augsburg (KORA)-Age
Study conducted in 2008–2009. This study is a follow-up
of all participants who took part in at least one of the four
cross-sectional MONICA (Monitoring of trends and de-
terminants in cardiovascular diseases)/KORA surveys
performed between 1984 and 2001 in the city of Augsburg
and the two adjacent counties. Altogether, 1,079 people
aged 65 years and older took part in the KORA-Age
Study. All participants were followed up for 3 years
regarding mortality. Participants with incomplete data on
mortality (outcome), maximum grip strength (predictor)
or potential confounders were excluded. The remaining
1,066 (530 men, 536 women) individuals were on average
76 years old (SD = 11). The study was approved by the
local authorities, and all subjects provided written in-
formed consent.
Grip strength
Handgrip strength was assessed using the Jamar dyna-
mometer (Saehan Corporation). The Jamar dynamom-
eter was placed in the participant’s dominant hand.
Three trials were allowed with brief pauses. Participants
were encouraged to exert their maximal grip strength in
kilograms (kg). The maximum value of three handgrip
measurements, divided into three groups using the
gender-specific tertiles as the cut-off points, was used in
the analyses.
Mortality
All-cause mortality during the time interval from enrol-
ment to the end of follow-up was the main outcome of
the study. Deaths were ascertained by checking the vital
status of all those sampled in the KORA-Age study
through the population registries inside and outside the
study area. Death certificates were obtained from local
health authorities.
Confounders
Potential confounders were chosen based on literature
research and expert opinions. Sociodemographic charac-
teristics of participants (including age at enrolment and
gender), body mass index (BMI) (calculated as weight
[kg]/height2 [m2]), lifestyle factors and nutritional status
were collected during a standardized face-to-face or tele-
phone interview, or during a personal examination. The
risk of impaired nutritional status was assessed using a
short version of the ‘Seniors in the Community: Risk
Evaluation for Eating and Nutrition, Version II’
(SCREEN II) questionnaire [15], in which lower values
correspond to a higher risk. In the present study, nutri-
tional status was classified into three groups using tertile
values as cut-off points. Leisure-time physical activity
during summer and winter was assessed based on two
separate questions with a four-level graded scale (0, <1,
1–2 and more than 2 h per week). The responses for
summer and winter were combined to define one variable
whereby a participant was considered active if he or she
participated in sports in summer and in winter and for
more than 1 h per week in at least one season. A partici-
pant was classified as inactive if he or she was less active
during leisure time. As previously described [16, 17], use of
medication and supplements was collected through a
database-supported computer software (IDOM: Instrument
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for data based assessment of medication). Participants were
asked to bring all product packages of ingested medications
and supplements to the study centre. The enquiry period
covered the last 7 days prior to the interview and partici-
pants’ mode of ingestion (regularly or irregularly, i.e. as
needed), mode of prescription (prescribed, recommended
by physician, self-medication), dosage and frequency of
ingestion were collected for each preparation. For the
present analysis, the variable ‘number of drugs’ includes
only regularly consumed drugs prescribed by a physician.
Dietary supplements and herbal products as well as hom-
oeopathic preparations were excluded. Information on
chronic diseases was collected through a self-administered
questionnaire mailed to participants or a standardized
telephone interview. Groups of chronic diseases were de-
fined as suggested by Chaudhry [18]. For the present ana-
lysis, cancer, lung diseases, heart diseases and stroke were
selected as potential confounders.
Statistical analysis
Descriptive results for continuous potential confounders
were presented as median and interquartile range (IQR)
and for categorical variables as frequencies (%). Log-rank
tests were performed to detect significant differences in
the survival times by categories of potential confounders.
Cox proportional hazards models with and without
adjustment for significant confounders were used to
examine the association between grip strength and all-
cause mortality. Three different models were calculated:
(1) basic model without adjustment for confounders; (2)
model adjusted for age and gender; and (3) model ad-
justed for significant confounders identified in the total
population based on the change-in-estimate criterion in
‘purposeful variable selection’ by Hosmer and Lemeshow
[19, 20]. The selection occurred in three steps: initially,
all variables with a significance level of <0.25 in the
univariate analyses were included. In the second step, all
variables with a p‐value higher than 0.10 or a relative
change of less than 20% in other regression coefficients
were eliminated in a stepwise manner. Finally, all vari-
ables that were not initially included because of a p-
value ≥0.25 in the univariate analyses re-entered the
model one by one, and the elimination criteria in the
second step were proofed for them. The results are pre-
sented as hazard ratios (HRs) and 95% confidence inter-
vals (95% CI) for all-cause mortality across gender-
specific incremental thirds of muscular strength using
the third tertile as the reference group. An adjusted
Kaplan–Meier curve for the predictor in the final model
was calculated and compared with the Kaplan–Meier
curve before adjusting for the confounders. As sensitivity
analysis, maximum grip strength values were included in
the model as a continuous variable, and HRs per 1 kg
increase in the maximum value of the grip strength
measurements were calculated. Furthermore, effect modi-
fication by gender with respect to the effect of grip
strength on mortality was tested by inclusion in the
models of an interaction term between grip strength and
gender. Age-adjusted mortality rates per 1,000 person
years across incremental gender-specific thirds of muscu-
lar strength with 95% confidence intervals were computed
for men and women. Data analysis was performed using




Maximum grip strength and selected baseline character-
istics of the 1,066 included individuals (530 men/536
women) stratified by gender are presented in Table 1.
Maximum grip strength had a median (IQR) of 28 (6) kg
in the first, 36 (2) kg in the second and 44 (8) kg in the
third tertile in men, and 16 (6) kg, 22 (4) kg and 28 (4)
kg in women. Overall, 34%, 34% and 32% of men and
36%, 41% and 23% of women belonged to the first, sec-
ond and third tertiles respectively. Men were more ac-
tive (p-values = 0.0046) and had better nutritional status
(p-values <0.0001). Median age, BMI and number of pre-
scribed medications consumed regularly as well as the
prevalence of major chronic diseases were almost the
same in men and women.
Association between grip strength and mortality
Table 2 presents the number of deaths by tertiles of
maximum grip strength for both men and women. The
mean grip strength (±SD) was 34.7 (±8.7) kg and 20.7
(±6.0) kg for men and women respectively. Over the
follow-up time period (2008 – 2011), 95 participants died
(56 men and 39 women). Age-adjusted mortality rates per
1,000 person years across incremental gender-specific
thirds of muscular strength (95% CI) were 77 (59–106), 24
(13–41) and 14 (7–30) for men and 57 (39–81), 14 (7–27)
and 1 (0–19) for women.
Table 3 summarizes the results of the Cox propor-
tional hazards models for the association between
tertiles of maximum grip strength and all-cause mortal-
ity, with and without adjustment for different combina-
tions of confounders in the total study population and
stratified by gender.
After multivariable adjustment, HRs (95% CI) for all-
cause mortality by tertiles of maximum grip strength were
5.23 (0.67–40.91) in women for the first tertile and 2.17
(0.27–17.68) for the second tertile versus the reference
group (third tertile). In men, the respective HRs were 2.37
(0.97–5.75) and 0.97 (0.36–2.57). In a model combining
data from men and women, multivariable adjusted HRs
were 3.33 (1.53–7.22) and 1.42 (0.61–3.28) for the first
and second tertiles respectively. The interaction between
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gender and grip strength tertiles was not statistically
significant (p-value = 0.2174). Figure 1 shows the Kaplan–
Meier survival curves according to tertiles of the max-
imum grip strength after adjustment for confounders in
men and women.
Discussion
The results of our study demonstrate that low handgrip
strength is associated with all-cause mortality among
older men and women from the general population after
controlling for significant confounders, including age,
nutritional status, number of prescribed drugs, diseases
and level of physical activity. Further, we observed
gender-specific differences with HRs being more than
twice as high in women than in men. However, gender
differences were not statistically significant, possibly be-
cause of the relatively small number of deaths especially
in women.
Few studies have examined the effect of gender on the
association between muscle strength and mortality with
inconsistent findings [7, 10, 13, 14, 21, 22]. In three of
them, muscle strength was not predictive of mortality in
women [7, 14, 22], whereas three other studies [10, 13, 21]
reported a significantly increased risk of mortality for
women in the lowest quartile of grip strength. In the
above studies, only three studies adjusted for physical
Table 2 Number of deaths and mortality rates in men and women by tertiles of grip strength during the follow-up time in the
KORA-Age Study (2008 – 2011)
Men Maximum grip strength ≤30 kg Maximum grip strength >30– < 38 kg Maximum grip strength >38 kg Total
Alive (n (%)) 144 (80%) 168 (93%) 162 (96%) 474 (89%)
Dead (n (%)) 37 (20%) 12 (7%) 7 (4%) 56 (11%)
Total 181 180 169 530
Mortality ratea 77 (59–106) 24 (13–41) 14 (7–30) 39 (31–51)
Women Maximum grip strength ≤18 kg Maximum grip strength >18– < 24 kg Maximum grip strength >24 kg Total
Alive (n (%)) 162 (85%) 210 (96%) 125 (99%) 497 (93%)
Dead (n (%)) 29 (15%) 9 (4%) 1 (1%) 39 (7%)
Total 191 219 126 536
Mortality ratea 57 (39–81) 14 (7–27) 1 (0–19) 25 (19–35)
aper 1,000 person years (95% CI)
Table 1 Participant characteristics of the KORA-Age Study (2008 – 2011) stratified by gender (n = 1,066)
Men (n = 530) Women (n = 536)
Maximum grip strength, kg, median (IQRa) 35 (10) 22 (6)
Lowb 28 (6) 16 (6)
Moderate 36 (2) 22 (1)
High 44 (8) 28 (4)
Age, years (median (IQR)) 76 (11) 76 (11)
BMI, kg/m2 (median (IQR)) 27.9 (5) 27.9 (6)
SCREEN II nutritional status (n (%))
≤ 36 points 152 (29) 199 (37)
> 36; ≤41 points 188 (35) 213 (40)
> 41 points 190 (36) 124 (23)
Physical activity (n (%))
Active 303 (57) 260 (48)
Inactive 227 (43) 276 (52)
Number of prescribed drugs (median (IQR)) 3 (4) 3 (3)
Cancer (n (%)) 27 (5) 16 (3)
Cardiovascular diseases (n (%)) 198 (37) 180 (34)
Lung diseases (n (%)) 60 (11) 54 (10)
aIQR interquartile range. bLow: men, ≤30 (kg); women, ≤18 (kg). Moderate: men, >30 (kg) and ≤38 (kg); women, >18 (kg) and ≤24 (kg). High: men, >38 (kg);
women, >24 (kg)
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activity [7, 21, 22]. We included level of physical activity,
medical status and number of prescribed drugs, and we
also accounted for nutritional status, all of which are inde-
pendent predictors of mortality, in our final model.
Although nutritional status was significantly associated
with mortality (p-value = 0.01) and with grip strength (p-
value = 0.0014), it was only a modest confounder of the
association between grip strength and mortality. The HR
in the full model without adjustment for nutritional status
was 3.21 (1.48–6.98) for the first tertile versus the third
tertile. Our results extend the limited literature by show-
ing that, compared with men, it appears to be more im-
portant for older women to enhance their levels of
muscular strength in order to reduce the risk of all-cause
mortality [10, 13, 21]. The presence of chronic diseases
commonly underlying death, nutritional status and phys-
ical activity did not explain the association, indicating that
muscle strength may predict mortality through other
mechanisms, such as factors secreted from the muscle
cells, classified as myokines, which may protect against
premature death [23].
In addition, little is known about the level of muscular
strength required to protect against the risk of prema-
ture death. Data from the Aerobic Center Longitudinal
Study, a prospective study of 8,762 men aged between
20 and 80 years, reported similar risk reductions in
people with medium versus high muscular strength [9,
12], suggesting that having high levels in comparison
with moderate levels of muscular strength does not pro-
vide additional protection. Indeed, in our study, men
showed an elevated risk of mortality only when they had
low levels of muscular strength (<30 kg), whereas
women tended to show a higher risk of all-cause mortal-
ity with moderate muscular strength (between 18 and
24 kg) compared with those in the highest tertile of
muscular strength. However, it has to be kept in mind
that none of the individual HRs was statistically signifi-
cant and, therefore, larger studies examining possible
dose–response relationships and gender differences are
urgently needed. The question arises whether the initial
level or the rate of change in grip strength is more pre-
dictive of mortality. Danish data revealed significantly
greater change for grip strength in men compared with
women in later life, whereas the decline in grip strength
was non-linear in women with a more pronounced
decline with increasing age [24]. The data further sug-
gested that the initial level of grip strength was more
predictive of mortality than the rate of change, and the
predictive effects were similar in men and women.
Our results suggest that older women are more sensi-
tive to muscle strength alterations throughout ageing,
probably as a result of sex differences in muscle mass as
well as hormonal factors [25, 26]. It seems to be particu-
larly important for the weakest to enhance their levels of
muscular strength and build up muscle mass early in
life, where targeted preventative efforts may be launched,
to reduce their risk of premature death. On the other
side, however, small improvements in strength levels
(moving from the low to the middle tertile) may trans-
late into great benefits in mortality risk reduction.
Ultimately, randomized clinical trials with interventions
aiming to increase muscular strength have to demon-
strate whether increases in muscle strength at older ages
indeed translate into reduced mortality rates.
The underlying mechanisms behind the benefits of
muscular strength on mortality are still unclear but
appear to be multifactorial. As there is a strong associ-
ation between muscle strength and skeletal muscle mass,
which is unquestionably a major tissue responsible for
blood glucose disposal on account of its sheer size and
ability to respond to insulin, the decline in muscle mass
with age is linked to an increased risk of metabolic dis-
eases such as type 2 diabetes associated with substantial
premature death [27]. The findings of a recent study of
4,066 individuals, aged 20–85 years, revealed that, for
every 0.05 decrement in grip strength (normalized as
strength per body mass), there was a 1.26 times in-
creased adjusted odds of diabetes in men and women
[28]. The gender- and age-specific weakness thresholds
to detect diabetes were lower in women than in men. In
the past few years, skeletal muscle has been identified as
a secretory organ producing and releasing several cyto-
kines in response to contraction, which have been
named myokines; these can influence the metabolism
Table 3 Crude and adjusted hazard ratios of all-cause mortality
for tertiles of maximum grip strength in the KORA-Age Study
(2008 – 2011)
Grip strength Model 1 Model 2 Model 3
Men
Low 5.49 (2.45–12.3) 2.55 (1.04–6.22) 2.37 (0.97–5.75)
Moderate 1.66 (0.65–4.21) 1.12 (0.43–2.91) 0.97 (0.36–2.57)
High 1 1 1
Women
Low 20.96 (2.56–154) 7.24 (0.94–56) 5.23 (0.67–40.9)
Moderate 5.17 (0.66–40.8) 2.87 (0.36–23) 2.17 (0.26–17.7)
High 1 1 1
Total study population
Low 7.20 (3.45–14.99) 3.11 (1.42–6.85) 3.33 (1.53–7.22)
Moderate 1.96 (0.87–4.43) 1.31 (0.57–3.01) 1.42 (0.61–3.28)
High 1 1 1
Model 1: unadjusted. Model 2: adjusted for age (in the total study population,
adjusted for both age and gender). Model 3: further adjusted for age,
nutritional status: tertiles 1/2 vs. 3, physical inactivity, number of prescribed
drugs, lung diseases, CVD, cancer (in the total study population, also adjusted
for gender). Grip strength: low: men ≤30/women ≤18 (kg), moderate: men
>30– ≤ 38/women >18– ≤ 24 (kg) and high: men >38/women >24 (kg)
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and function of muscle tissue and may counteract the
harmful effects of proinflammatory adipokines [23].
Indeed, associations between chronic low-grade inflam-
mation and sarcopenia are observed quite consistently,
and inflammatory markers showed negative associations
with both muscle mass [29] and strength [30, 31], as well
as physical function [32]. Recent findings from the
KORA-Age Study demonstrate higher concentrations of
interleukin-6 and hs-CRP in older individuals with lower
levels of muscular strength, independent of disease state,
suggesting that the muscular system per se is effective in
reducing low-grade inflammation [33]. Visceral fat has a
high metabolic activity with deleterious effects on health
contributing to muscle weakness and the frailty syn-
drome [34]. For example, the Baltimore Longitudinal
Study of Aging has demonstrated in 786 individuals with
a mean age of 66.3 years that adiposity is a significant
predictor of lower muscle quality and strength [35]. The
Toledo Study for Healthy Aging, a prospective study of
1,741 individuals aged ≥65 years, found a gender-specific
nonlinear relationship between waist to hip ratio (WHR,
a measure of central adiposity) and muscle strength [36].
In women, a normal BMI combined with either high or
low WHRs were associated with a decrease or increase
in strength, respectively. In contrast, men achieved their
maximum strength at a WHR around 1 and the highest
BMI. Thus, muscle strength may be determined by the
relationship between WHR and BMI depending on
gender. According to the Falls Risk and Osteoporosis
Longitudinal Study in 171 men and women, aged 60–88
years old, better diet quality in females is associated with
lower BMI and fat mass and higher lean mass, compared
with males who appear to have better physical function,
are less likely to self-report falls risk and have a better fat
distribution, i.e. a lower android/gynoid ratio, which was
significantly associated with better diet quality [37]. More-
over, low handgrip strength is a strong predictor of falls
[38] and osteoporotic fractures [39], physical disability and
Fig. 1 Adjusted Kaplan–Meier survival curves stratified by maximum grip strength tertiles for men and women in the KORA-Age Study (2008 – 2011)
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frailty [40], which in turn have been found to be related to
increased mortality risk [41]. It is, therefore, important for
clinicians to be able to identify patients for whom low
muscle strength is an important cause of their weakness
because they are the most likely to benefit from therapies
such as resistance training through enhanced muscle mass
but also improved neural factors including motor unit
recruitment and synchronization [42]. Thus, the assess-
ment of grip strength could be a useful tool in clinical
practice to identify older people with very low muscle
strength at the greatest risk of all-cause mortality.
This study has several strengths and limitations. A
major strength of this study was the prospective design,
the inclusion of a number of participants aged ≥80 years
and the use of an objective and standardized test for the
assessment of maximal muscular strength. Limitations of
the study are the relatively small sample size and short
follow-up time. However, in old age, muscle atrophy can
proceed dramatically, and even relatively small changes
in muscle strength may have a significant impact on pre-
dictors of mortality such as glucose disposal, low-grade
inflammation and osteoporotic fractures. Although we
have adjusted for several confounding factors such as age,
nutritional status, physical activity and chronic diseases,
we were unable to adjust for cardiorespiratory fitness,
which has been shown to be an independent predictor of
all-cause mortality. Finally, as this is an observational
study, we could only assess statistical associations and not
causal relationships. Ultimately, randomized intervention
studies aiming to increase muscular strength in older
adults have to show whether the observed associations are
causal and whether premature death can be prevented by
increasing muscular strength.
Conclusions
The findings of this study suggest that low muscle
strength is inversely associated with mortality in old age,
independent of potential confounders including age,
nutritional status, number of prescribed drugs, chronic
diseases and level of physical activity. This association
tended to be stronger in women. Thus, the implementa-
tion of resistance exercise training for the weakest may
be a promising means of reducing the adverse effects of
low muscle strength on mortality and should be further
tested in randomized clinical trials.
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